Late gadolinium enhancement and the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
作者信息
Bluemke David A
机构信息
Department of Radiology, The University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI 53792, USA.
出版信息
J Cardiovasc Magn Reson. 2024;26(2):101075. doi: 10.1016/j.jocmr.2024.101075. Epub 2024 Jul 31.
Abstract
摘要
相似文献
1
Late gadolinium enhancement and the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
J Cardiovasc Magn Reson. 2024;26(2):101075. doi: 10.1016/j.jocmr.2024.101075. Epub 2024 Jul 31.
2
[Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance].
Rev Esp Cardiol. 2011 Dec;64(12):1114-22. doi: 10.1016/j.recesp.2011.07.014. Epub 2011 Oct 24.
3
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
Circulation. 2020 Jun 9;141(23):1872-1884. doi: 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6.
4
Cardiac MRI and Clinical Outcomes in Arrhythmogenic Cardiomyopathy.
Radiol Cardiothorac Imaging. 2023 Dec;5(6):e230155. doi: 10.1148/ryct.230155.
5
Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Circ Cardiovasc Imaging. 2018 Sep;11(9):e007546. doi: 10.1161/CIRCIMAGING.118.007546.
6
Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings.
Circ Arrhythm Electrophysiol. 2020 Dec;13(12):e009005. doi: 10.1161/CIRCEP.120.009005. Epub 2020 Dec 15.
7
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy.
J Am Heart Assoc. 2021 Sep 21;10(18):e021987. doi: 10.1161/JAHA.121.021987. Epub 2021 Sep 17.
8
Utilization of sacubitril-valsartan for right ventricular failure in a patient with arrhythmogenic right ventricular cardiomyopathy.
Future Cardiol. 2022 Jul;18(7):547-552. doi: 10.2217/fca-2021-0148. Epub 2022 Jun 15.
9
Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging.
Circ Arrhythm Electrophysiol. 2017 Jul;10(7). doi: 10.1161/CIRCEP.116.005105.
10
Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.
Heart Rhythm. 2018 Jul;15(7):987-993. doi: 10.1016/j.hrthm.2018.02.030. Epub 2018 Mar 2.
本文引用的文献
1
Diagnostic value of late gadolinium enhancement at cardiovascular magnetic resonance to distinguish arrhythmogenic right ventricular cardiomyopathy from differentials.
J Cardiovasc Magn Reson. 2024;26(2):101059. doi: 10.1016/j.jocmr.2024.101059. Epub 2024 Jul 8.
2
The Specificity of Left Ventricular Bite-Like Fibrofatty Replacement for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy.
JACC Cardiovasc Imaging. 2024 Sep;17(9):1113-1115. doi: 10.1016/j.jcmg.2024.03.011. Epub 2024 May 8.
3
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria.
Int J Cardiol. 2020 Nov 15;319:106-114. doi: 10.1016/j.ijcard.2020.06.005. Epub 2020 Jun 16.
4
Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.
Circ Genom Precis Med. 2019 Aug;12(8):e002467. doi: 10.1161/CIRCGEN.119.002467. Epub 2019 Aug 6.
5
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.
Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.
6
Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy.
Biophys Rev. 2018 Aug;10(4):973-982. doi: 10.1007/s12551-018-0437-0. Epub 2018 Jul 11.
7
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.
Eur Heart J. 2010 Apr;31(7):806-14. doi: 10.1093/eurheartj/ehq025. Epub 2010 Feb 19.
8
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.
Heart Rhythm. 2009 Jul;6(7):984-92. doi: 10.1016/j.hrthm.2009.03.013. Epub 2009 Mar 11.
9
Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.
J Am Coll Cardiol. 2008 Dec 16;52(25):2175-87. doi: 10.1016/j.jacc.2008.09.019.
10
Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.
Circulation. 2006 Apr 11;113(14):1807-16. doi: 10.1161/CIRCULATIONAHA.106.174287. Epub 2006 Mar 27.
Zotero 插件